Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Objective and Subjective Efficacy of Natalizumab on Disability and Fatigue in Relapsing Remitting (RR) and Relapsing Progressive (RP) Multiple Sclerosis (MS) over a 2 Year Period
MS and Related Diseases
(-)
148
Authors/Disclosures
Doumos Loannis No disclosure on file
Vassiliki Kotsi No disclosure on file
Elissaios Karageorgiou, MD, PhD, FÂ鶹´«Ã½Ó³»­ (Neurological Institute of Athens) Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union. The institution of Dr. Karageorgiou has received research support from Alzheimer's Association.
No disclosure on file
Dimitrios Tzortzis No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Helen Papageorgiou, MD No disclosure on file
Sofia Tsiara, MD No disclosure on file